Adults over the age of 45 who consumed 24 ounces or more of sugary beverages had twice the risk of death from coronary artery disease (CAD) than people who drank less than one ounce, according to new research.

Women 60 and older who take antibiotics for more than a couple of months have a higher risk of all-cause and cardiovascular death, according to research presented March 22 at the American Heart Association’s Epidemiology and Prevention/Lifestyle and Cardiometabolic Health scientific sessions.

Many people don’t know they have cardiovascular disease until they end up in the hospital with myocardial infarction. But a few strange external signs could signal all is not right with the heart, an anatomy professor noted in The New Zealand Times.

Medicare was the primary payer for 90 percent of transcatheter aortic valve replacement (TAVR) hospitalizations over a recent three-year period, according to a March 19 report in JACC: Cardiovascular Interventions. With that in mind, the recent proposal to cut $473 billion from the CMS budget over the next decade could limit access to the increasingly popular procedure, researchers noted.

As physicians continue working later in life, health systems are confronted with a complex problem: How do you protect patients from physicians who develop Alzheimer’s disease or other forms of cognitive impairment while not unfairly penalizing those who are still competent?

New research presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2018 suggests individuals with depression may have an increased risk of developing atrial fibrillation (AFib).

Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion to include a new indication in the Repatha® (evolocumab) label for adults with established atherosclerotic cardiovascular disease (myocardial infarction, stroke or peripheral arterial disease) to reduce cardiovascular risk by lowering LDL-C levels.

Occluder devices to combat congenital structural heart defects designed by the indigenous Aymara women suggest “excellent” clinical outcomes and have been approved by regulatory agencies in Canada, South America and the European Union.

A high-sensitivity troponin I (hsTnI) assay was independently predictive of coronary artery disease (CAD) in patients with stable chest pain in the outpatient setting, researchers reported in JACC: Cardiovascular Imaging. However, it’s not ready to be used as a standalone diagnostic tool for CAD.

New research out of Japan shows eating slowly may positively affect changes in obesity, BMI and waist circumference.